Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Aevi Genomic Medicine (GNMX)

2.01 0.06 (3.08%)

02-23 16:00

Open:

1.89

Pre. Close:

1.95

High:

2.08

Low:

1.84

Volume:

236,185

Market Cap:

119M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.082 - 2.09

2.09 - 2.099

Low:

1.82 - 1.828

1.828 - 1.837

Close:

1.994 - 2.008

2.008 - 2.023

Technical analysis  (as of: 2018-02-23 4:41:03 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 3.10     One year: 3.62

Support:

Support1: 1.85    Support2: 1.35

Resistance:

Resistance1: 2.65    Resistance2: 3.10

Pivot:

2.17

Moving Averages:

MA(5): 2.02     MA(20): 2.10

MA(100): 1.52     MA(250): 1.66

MACD:

MACD(12,26): 0.12     Signal(12,26,9): 0.18

%K %D:

%K(14,3): 14.12     %D(3): 20.26

RSI:

RSI(14): 52.94

52-Week:

High: 6.18  Low: 0.98  Change(%): -59.6

Average Vol(K):

3-Month: 29903  10-Days 22708

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
GNMX has closed above bottom band by 23.0%. Bollinger Bands are 31.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 15 Dec 2016 13:11:04 GMT
Medgenics, Inc. Announces Name Change to Aevi Genomic Medicine, Inc.

Wed, 09 Sep 2015 12:22:30 GMT
Medgenics Acquires Phase 2-Ready CNS Program: NFC-1

Thu, 22 Feb 2018 21:33:45 GMT
Jefferies Group Weighs in on Medgenics Inc's FY2022 Earnings (NASDAQ:GNMX)

Sat, 29 Oct 2016 13:52:30 GMT
Medgenics Presents New Data Showing Prevalence of Genetic Mutations in ...

Tue, 21 Jun 2016 16:59:58 GMT
Why Medgenics Inc.'s Shares Are Down Big Today

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

59.33

Shares Float (M)

52.16

% Held by Insiders

% Held by Institutions

51.60

Shares Short (K)

432

Shares Short Prior Month (K)

373

Stock Financials

EPS

-0.960

EPS Est. Current Year

-0.850

EPS Est. Next Year

-0.750

EPS Est. Next Quarter

-0.160

Forward EPS

-0.711

Book Value (p.s.)

13.170

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-106.9

Return on Equity (ttm)

-131.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.605

Qtrly Earnings Growth

Operating Cash Flow (M)

-32.38

Levered Free Cash Flow (M)

-18.73

atoplab.com

Valuation

P/E

-2.09

P/E Growth Ratio

0.03

P/BV

0.15

P/S

P/CF

-3.68

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.